Meet Managing IP during November and December

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Meet Managing IP during November and December

Women in IP 168

We are hosting a number of events over the next few weeks, and will also be attending others so we hope to see you at some of them

Women in IP

ipwomen15-panel-400
Women in IP Forum 2015

Coming up soon is our International Women's Leadership Forum, which is in Palo Alto on November 29.  This is the third time this event has been held in California and this year's Forum is bigger and better than ever. It provides an opportunity for women working in IP to discuss topics including alternatives to litigation, practical strategies for patent protection and developments in licensing and trade marks. 

The event is inclusive, and men as well as women are welcome to attend. Registration is free for in-house counsel/heads of legal. Paid-for attendance includes Bronze level membership of the Women in IP Global Network. Register online here and find out more about  last year's event here.

European patent developments

EPF-NY-lunch
European Patent Reform Forum 2015

Next up are our two editions of the European Patent Forum USA, which are being held in Palo Alto on November 30 and New York City on December 2. These events provide a great opportunity for US practitioners (both in-house and in private practice) to get the latest news on developments in Europe. These include the impact of Brexit, the latest news on the Unitary Patent and UPC, enforcement and industry-specific issues.

As usual, registration is free for in-house practitioners: find out more here.

We have a number of other events planned for early next year in both the UK and US: see our events page for the latest news.

Meetings in London

Henry Carr QC
Mr Justice Carr

I'm also looking forward to attending a number of other events on our doorstep in London over the next few weeks, including: Do patents have a chilling effect on incentives for R&D? A debate organised by UCL IBIL and CIPA next Wednesday November 16 from 6pm. Tickets are £30/£25.50 and can be booked here.

Pharma IP - the in-house perspective: a discussion organised by AIPPI UK on November 22 starting at 5.30pm. Tickets are free (AIPPI UK members) or £25 (non-members) and the event is also webcast. Details here.

Address by Mr Justice Carr: the UK's newest patents judge will be speaking at the UNION Christmas Dinner on December 6. Ticket prices start at £50 and can be booked here.

more from across site and SHARED ros bottom lb

More from across our site

Erise IP has added a seven-practitioner trademark team from Hovey Williams, signalling its intention to help clients at all stages of development
News of prison sentences for ex-Samsung executives for trade secrets violation and an opposition filed by Taylor Swift were also among the top talking points
A multijurisdictional claim filed by InterDigital and a new spin-off firm in Germany were also among the top talking points
Duarte Lima, MD of Spruson & Ferguson’s Asia practice, says practitioners must adapt to process changes within IP systems, as well as be mindful of the implications of tech on their practices
Practitioners say the UK Supreme Court’s decision could boost the attractiveness of the UK for AI companies
New awards, including US ‘Firm of the Year’ and Latin America ‘Firm to Watch’, are among more than 90 prizes that will recognise firms and practitioners
DWF helped client Dairy UK secure a major victory at the UK Supreme Court
Hepworth Browne led Emotional Perception AI to victory at the UK Supreme Court, which rejected a previous appellate decision that said an AI network was not patentable
James Hill, general counsel at Norwich City FC, reveals how he balances fan engagement with brand enforcement, and when he calls on IP firms for advice
In the second of a two-part article, Gabrielle Faure-André and Stéphanie Garçon at Santarelli unpick EPO, UPC and French case law to assess the importance of clinical development timelines in inventive step analyses
Gift this article